Has NICE been nice to cancer?

European Journal of Cancer

Volumn 42, Issue 17, 2006, Pages 2881-2886

  Summerhayes, Maxwell ^a   Catchpole, Paul ^b  

^a Roche Products   (United Kingdom)

^b Healthcare Management   (United Kingdom)

Author keywords

Evidence based medicine; Government; Great Britain; Healthcare economics and organisations; National Health Service; Neoplasms

Indexed keywords

ANTINEOPLASTIC AGENT; ERLOTINIB; IRINOTECAN; OXALIPLATIN; TRASTUZUMAB;

ARTICLE; BIOMEDICAL TECHNOLOGY ASSESSMENT; CANCER; CANCER PATIENT; CLINICAL PRACTICE; COST EFFECTIVENESS ANALYSIS; HEALTH CARE ACCESS; HEALTH CARE AVAILABILITY; HEALTH CARE COST; HEALTH CARE SYSTEM; HUMAN; MEDICAL AUDIT; MEDICAL DECISION MAKING; NATIONAL HEALTH SERVICE; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; RESPONSIBILITY; UNITED KINGDOM;

ADVISORY COMMITTEES; ENGLAND; GOVERNMENT AGENCIES; HEALTH SERVICES ACCESSIBILITY; HUMANS; NEOPLASMS; PATIENT ADVOCACY; PRACTICE GUIDELINES; PROFESSIONAL PRACTICE; TECHNOLOGY ASSESSMENT, BIOMEDICAL; WALES;

EID: 33751103469     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2006.08.013     Document Type: Article

References (12)

1. Garner S. How decisions on the use of medicines and medical devices are made. Pharm J 275 (2005) 254-256
2. Mears R, Taylor R, Littlejohns P, Dillon A. Review of international health technology assessment (IHTA). Project report. http://www.nice.org.uk/page.aspx?o=17246 [accessed 12.10.05].
3. Oliver A., Mossialos E., and Robinson R. Health technology assessment and its influence on health care priority setting. Int J Technology Assessment in Health Care 20 (2004) 1-10
4. BBC Online Network Difficult decisions in the NHS. http://news.bbc.co.uk/1/hi/health/192464.stm [accessed 12.10.05].
5. BBC Online Network NHS body 'to end postcode prescribing'. http://news.bbc.co.uk/1/hi/health/271522.stm [accessed 12.10.05].
6. Department of Health. The NHS Plan: a plan for investment, a plan for reform (2000), Department of health, London
7. http://www.nice.org.uk.
8. National Institute for Clinical Excellence. Technology Appraisal Guidance No. 33. Guidance on the use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer (2002), National Institute for Clinical Excellence, London
9. Department of Health. Directions to Primary Care Trusts and NHS Trusts in England concerning arrangements for the funding of technology appraisal guidance from the National Institute for Clinical Excellence. http://www.dh.gov.uk/assetRoot/04/07/56/86/04075686.pdf; 2003 [accessed 17.10.05].
10. Department of Health. Variations in usage of cancer drugs approved by NICE. Report of the review undertaken by the National Cancer Director. http://www.dh.gov.uk/assetRoot/04/08/38/95/04083895.pdf. [accessed 18.10.05.].
11. Department of Health. National Institute for Clinical Excellence: Arrangements for topic selection. Overview of new system. http://www.dh.gov.uk/assetRoot/04/03/27/68/04032768.pdf [accessed 18.10.05.].
12. NHS Executive. National Institute for Clinical Excellence: Initial work programme. HSC 1999/176. http://www.dh.gov.uk/assetRoot/04/01/21/25/04012125.pdf [accessed 18.10.05.].